Key Record Dates
ClinicalTrials.gov Identifier: | NCT02500407 |
---|---|
Brief Title: | A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) |
First Submitted : | July 14, 2015 |
First Submitted that Met QC Criteria : | July 14, 2015 |
First Posted : | July 16, 2015 (Estimate) |
Last Update Submitted that Met QC Criteria : | May 14, 2023 |
Last Update Posted : | May 16, 2023 |